Advanced Search
WANG Qingsong, HUANG Ting, ZHANG Can, PING Qineng. Comparative study on the two crystal forms of iguratimod[J]. Journal of China Pharmaceutical University, 2014, 45(3): 331-334. DOI: 10.11665/j.issn.1000-5048.20140314
Citation: WANG Qingsong, HUANG Ting, ZHANG Can, PING Qineng. Comparative study on the two crystal forms of iguratimod[J]. Journal of China Pharmaceutical University, 2014, 45(3): 331-334. DOI: 10.11665/j.issn.1000-5048.20140314

Comparative study on the two crystal forms of iguratimod

More Information
  • The aim of this study was to compare the physicochemical properties and in vivo behavior of two crystal forms of iguratimod. The different crystal forms of iguratimod were prepared and their physicochemical properties were studied by DSC and XRPD. The absorptions of the crystal forms α and β was compared by administering iguratimod to SD rats. It was found that the melting points and solubilities, as well as pharmacokinetic parameters of crystal forms α and β were similar. No significant difference was found in biological activity in the rats between them. Meanwhile, the flowability and compressibility of crystal form β were better than those for form α. Therefore, the crystal form β is more suitable for the development of solid formulation.
  • [1]
    Lü Y,Du GH.Polymorphic Drugs(晶型药物)[M].Beijing:People′s Medical Publishing House,2009:15.
    [2]
    Ren W,Sun JX.Effect of polymorphs in pharmaceutical preparations[J].Med Front(医药前沿),2011,1(18):53-55.
    [3]
    Tanaka K.Iguratimod(T-614):a novel disease-modifying anti-rheumatic drug[J].Rheumatol Rep,2009,1(1):11-15.
    [4]
    Zhang YC,Wang F,Wang WY,et al.New drug for rheumatoid arthritis:iguratimod[J].World Clin Drugs(世界临床药物),2013,34(2):65-69.
    [5]
    Shen JL,Jiang Q,Zhang JS.Research Advance of Drug Polymorphism[J].Chin Hosp Pharm J(中国医院药学杂志),2001,21(5):304-305.
  • Related Articles

    [1]Studies on Pharmacokinetics and Relative Bioavailability of Aceclofenac Controlled-Release Tablets in Dogs[J]. Journal of China Pharmaceutical University, 2004, (5): 57-59.
    [2]Determination of Finasteride and Its Pharmacokinetics in Human Plasma by HPLC[J]. Journal of China Pharmaceutical University, 2004, (2): 90-92.
    [3]Pharmacokinetic Study on the Sustained-release Tablets of Labetalol in Dogs[J]. Journal of China Pharmaceutical University, 2003, (6): 48-52.
    [4]Determination of Propylthiouracil and Its Pharmacokinetics in Human Plasma by an Improved HPLC Method[J]. Journal of China Pharmaceutical University, 2001, (5): 45-48.
    [5]Determination ofRepaglinide in Plasma by HPLC and Its Pharmacokinetics in Men[J]. Journal of China Pharmaceutical University, 2001, (1): 32-35.
    [6]Establishment of HPLC for the Determination of Fluorouracil in Biological Sample s and Study on Its Pharmacokinetics in Mice[J]. Journal of China Pharmaceutical University, 2000, (6): 34-37.
    [7]Determination of Nefopam in Plasma by HPLC[J]. Journal of China Pharmaceutical University, 2000, (5): 45-47.
    [8]Determination of Rotundine in Human Plasma by HPLC and Pharmacokinetic Studies[J]. Journal of China Pharmaceutical University, 1998, (1): 69-72.
    [9]Determination of Flunarizine in Human Plasma by HPLCand its Pharmacokinetics in Man[J]. Journal of China Pharmaceutical University, 1995, (5): 300-303.
    [10]Pharmacokinetics and Relative Bioavailability of Tamoxifen in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 1995, (2): 84-86.

Catalog

    Article views (1816) PDF downloads (1682) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return